Variant report
Variant | nsv900802 |
---|---|
Chromosome Location | chr13:88948150-89024299 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:9)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:9 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK6-19 | chr13:88950629-88950764 | NONHSAT034611 |
2 | lnc-SLITRK5-18 | chr13:89001068-89001533 | l_896_chr13:89001067-89003744_testes |
3 | lnc-SLITRK6-20 | chr13:88998946-88999466 | NONHSAT034612 |
4 | lnc-SLITRK6-20 | chr13:89003986-89004059 | NONHSAT034612 |
5 | lnc-SLITRK6-20 | chr13:89001456-89001545 | NONHSAT034612 |
6 | lnc-SLITRK5-18 | chr13:89001824-89001971 | l_896_chr13:89001067-89003744_testes |
7 | lnc-SLITRK5-18 | chr13:89002360-89003744 | l_896_chr13:89001067-89003744_testes |
8 | lnc-SLITRK6-20 | chr13:89001488-89001532 | NONHSAT034613 |
9 | lnc-SLITRK6-20 | chr13:89002360-89002644 | NONHSAT034613 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35116017 | chr13:88950640-88950641 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs539222753 | chr13:88950660-88950661 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs147822523 | chr13:88950666-88950667 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs34285730 | chr13:88950712-88950713 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs547050700 | chr13:88955404-88955405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565443060 | chr13:88955419-88955420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532937013 | chr13:88955491-88955492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551318701 | chr13:88955494-88955495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558230273 | chr13:88955511-88955512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373638905 | chr13:88955531-88955532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376679186 | chr13:88955533-88955534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536990058 | chr13:88955610-88955611 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556509345 | chr13:88955639-88955640 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112062001 | chr13:88955660-88955661 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184231777 | chr13:88955679-88955680 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554279166 | chr13:88955688-88955689 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141580764 | chr13:88955699-88955700 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187807279 | chr13:88955719-88955720 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150506357 | chr13:88955726-88955727 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79663816 | chr13:88955744-88955745 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576672484 | chr13:88955749-88955750 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569353307 | chr13:88955756-88955757 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543803869 | chr13:88955780-88955781 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562055471 | chr13:88955805-88955806 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528815240 | chr13:88955830-88955831 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540649791 | chr13:88955837-88955838 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543990768 | chr13:88955845-88955846 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371610101 | chr13:88955849-88955850 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558992209 | chr13:88955862-88955863 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532889575 | chr13:88955884-88955885 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192293584 | chr13:88955903-88955904 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569789107 | chr13:88955904-88955905 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139486234 | chr13:88955926-88955927 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548959379 | chr13:88955952-88955953 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184391582 | chr13:88955953-88955954 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188751917 | chr13:88955988-88955989 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529982354 | chr13:88955996-88955997 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566156910 | chr13:88956017-88956018 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539595203 | chr13:88956026-88956027 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61960901 | chr13:88956029-88956030 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs576521520 | chr13:88956049-88956050 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570758627 | chr13:88956074-88956075 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555614828 | chr13:88956079-88956080 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192817641 | chr13:88956098-88956099 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548209028 | chr13:88956128-88956129 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74562945 | chr13:88956158-88956159 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533035286 | chr13:88956160-88956161 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544735769 | chr13:88956171-88956172 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532410985 | chr13:88956173-88956174 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149686429 | chr13:88956226-88956227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:88955400-88955600 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr13:88955600-88955800 | Enhancers | Primary B cells from cord blood | blood |
3 | chr13:88955600-88956000 | Active TSS | Primary B cells from peripheral blood | blood |
4 | chr13:88955600-88956200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr13:88955800-88956200 | Flanking Active TSS | Primary B cells from cord blood | blood |
6 | chr13:88956000-88957000 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr13:88956200-88956600 | Enhancers | Primary B cells from cord blood | blood |
8 | chr13:88970400-88970600 | Enhancers | Pancreas | Pancrea |
9 | chr13:88972200-88973000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:88997000-89002000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr13:88998000-88998200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr13:89002200-89002600 | Enhancers | Fetal Heart | heart |
13 | chr13:89008000-89008200 | Enhancers | Gastric | stomach |
14 | chr13:89013000-89013200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr13:89013000-89013400 | Enhancers | Fetal Heart | heart |
16 | chr13:89021200-89021800 | Enhancers | Fetal Lung | lung |